15 March 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Uremia, and Insulin-Dependent Diabetes
Xitao HongDOI: 10.12659/AOT.935860
Ann Transplant 2022; 27:e935860
Table 3 Multiorgan liver-pancreas-kidney transplantation.
| Ref. | Grafts | Immunosuppressive program | Complication | Graft function recovery time | Follow-up time | ||
|---|---|---|---|---|---|---|---|
| Liver | Kidney | Pancrea | |||||
| Jiang Li et al, 2017 | LiverDuodenopancreasKidney | Basiliximab, tacrolimus, mycophenolate mofetil, and steroids | Non | 15 days | 15 days | 3 weeks | 3 weeks |
| Tzakis AG et al, 2015 | LiverPancreasKidney | Tacrolimus and steroids | All three transplanted organs acute rejection | 2 months | 2 months | 2 months | 18 months |
| Rivera E et al, 2016 | LiverPancreasKidney | Thymoglobulin, tacrolimus, mycophenolate mofetil, and steroids | Liver and pancreas acute rejection | NA | 45 days | NA | 18 months |
| Zhang G et al, 2020 | LiverDuodenopancreasKidney | rabbit anti-human thymocyte immunoglobulin (ATG), FK506, mycophenolate mofetil (MMF), prednisone acetate (Pred) | Transplant again for the kidney acute rejection | 7 days | 20 days | 7 days | 14 years |
| Luis A et al, 2017 | LiverPancreasKidney | Tacrolimus, mycophenolate mofetil, prednisolone | Non | NA | NA | NA | NA |
| NA – not applicable. | |||||||






